Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033358175> ?p ?o ?g. }
- W3033358175 endingPage "1703" @default.
- W3033358175 startingPage "1677" @default.
- W3033358175 abstract ": Computer-Aided Drug Design (CADD) techniques have garnered a great deal of attention in academia and industry because of their great versatility, low costs, possibilities of cost reduction in in vitro screening and in the development of synthetic steps; these techniques are compared with highthroughput screening, in particular for candidate drugs. The secondary metabolism of plants and other organisms provide substantial amounts of new chemical structures, many of which have numerous biological and pharmacological properties for virtually every existing disease, including cancer. In oncology, compounds such as vimblastine, vincristine, taxol, podophyllotoxin, captothecin and cytarabine are examples of how important natural products enhance the cancer-fighting therapeutic arsenal. : In this context, this review presents an update of Ligand-Based Drug Design and Structure-Based Drug Design techniques applied to flavonoids, alkaloids and coumarins in the search of new compounds or fragments that can be used in oncology. : A systematical search using various databases was performed. The search was limited to articles published in the last 10 years. : The great diversity of chemical structures (coumarin, flavonoids and alkaloids) with cancer properties, associated with infinite synthetic possibilities for obtaining analogous compounds, creates a huge chemical environment with potential to be explored, and creates a major difficulty, for screening studies to select compounds with more promising activity for a selected target. CADD techniques appear to be the least expensive and most efficient alternatives to perform virtual screening studies, aiming to selected compounds with better activity profiles and better “drugability”." @default.
- W3033358175 created "2020-06-12" @default.
- W3033358175 creator A5005777262 @default.
- W3033358175 creator A5010053154 @default.
- W3033358175 creator A5012850312 @default.
- W3033358175 creator A5025613707 @default.
- W3033358175 creator A5058068919 @default.
- W3033358175 creator A5067791299 @default.
- W3033358175 creator A5083832175 @default.
- W3033358175 date "2020-09-14" @default.
- W3033358175 modified "2023-10-16" @default.
- W3033358175 title "Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents" @default.
- W3033358175 cites W1161204293 @default.
- W3033358175 cites W1260134115 @default.
- W3033358175 cites W1495117561 @default.
- W3033358175 cites W1803513110 @default.
- W3033358175 cites W1835579797 @default.
- W3033358175 cites W1964898641 @default.
- W3033358175 cites W1968502990 @default.
- W3033358175 cites W1969996239 @default.
- W3033358175 cites W1978872704 @default.
- W3033358175 cites W1980719289 @default.
- W3033358175 cites W1984290896 @default.
- W3033358175 cites W1984341140 @default.
- W3033358175 cites W1986300386 @default.
- W3033358175 cites W1987792429 @default.
- W3033358175 cites W1988195734 @default.
- W3033358175 cites W1989296812 @default.
- W3033358175 cites W1992384606 @default.
- W3033358175 cites W1999460643 @default.
- W3033358175 cites W1999826720 @default.
- W3033358175 cites W2000563232 @default.
- W3033358175 cites W2000743925 @default.
- W3033358175 cites W2003141219 @default.
- W3033358175 cites W2007186785 @default.
- W3033358175 cites W2009277432 @default.
- W3033358175 cites W2009770328 @default.
- W3033358175 cites W2011498883 @default.
- W3033358175 cites W2011680286 @default.
- W3033358175 cites W2013225336 @default.
- W3033358175 cites W2014864738 @default.
- W3033358175 cites W2015058883 @default.
- W3033358175 cites W2016057437 @default.
- W3033358175 cites W2017027509 @default.
- W3033358175 cites W2021505095 @default.
- W3033358175 cites W2021860357 @default.
- W3033358175 cites W2023001077 @default.
- W3033358175 cites W2024182951 @default.
- W3033358175 cites W2025436220 @default.
- W3033358175 cites W2025813673 @default.
- W3033358175 cites W2026283619 @default.
- W3033358175 cites W2028989607 @default.
- W3033358175 cites W2029963983 @default.
- W3033358175 cites W2030112295 @default.
- W3033358175 cites W2031390939 @default.
- W3033358175 cites W2034332749 @default.
- W3033358175 cites W2037816363 @default.
- W3033358175 cites W2041089613 @default.
- W3033358175 cites W2041163647 @default.
- W3033358175 cites W2042086711 @default.
- W3033358175 cites W2044531485 @default.
- W3033358175 cites W2046119958 @default.
- W3033358175 cites W2049970665 @default.
- W3033358175 cites W2051124828 @default.
- W3033358175 cites W2055611284 @default.
- W3033358175 cites W2056967256 @default.
- W3033358175 cites W2057638850 @default.
- W3033358175 cites W2060535691 @default.
- W3033358175 cites W2063299574 @default.
- W3033358175 cites W2063551478 @default.
- W3033358175 cites W2067064275 @default.
- W3033358175 cites W2072417089 @default.
- W3033358175 cites W2073588128 @default.
- W3033358175 cites W2074296318 @default.
- W3033358175 cites W2075244876 @default.
- W3033358175 cites W2077023179 @default.
- W3033358175 cites W2079851635 @default.
- W3033358175 cites W2084009756 @default.
- W3033358175 cites W2085732173 @default.
- W3033358175 cites W2085921275 @default.
- W3033358175 cites W2090248730 @default.
- W3033358175 cites W2095384560 @default.
- W3033358175 cites W2096549907 @default.
- W3033358175 cites W2098072562 @default.
- W3033358175 cites W2100973429 @default.
- W3033358175 cites W2102475188 @default.
- W3033358175 cites W2105718579 @default.
- W3033358175 cites W2111176027 @default.
- W3033358175 cites W2114524747 @default.
- W3033358175 cites W2116191481 @default.
- W3033358175 cites W2122371306 @default.
- W3033358175 cites W2124109702 @default.
- W3033358175 cites W2128531001 @default.
- W3033358175 cites W2129280925 @default.
- W3033358175 cites W2132834292 @default.
- W3033358175 cites W2132855396 @default.
- W3033358175 cites W2133190342 @default.
- W3033358175 cites W2133990480 @default.